Novocure’s TTFields therapy combined with chemo improved overall survival by 16.2 months compared to 14.16 months with chemo ...

Novocure plans to file for regulatory approval of TTFields in unresectable, locally advanced pancreatic adenocarcinoma based ...

To the best of our knowledge, this is the first study to provide information about feasibility and tolerability of the combination cisplatin/gemcitabine in the adjuvant treatment of NSCLC.

Novocure Announces Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer ...

Dr. Reddy's Laboratories launches Toripalimab in India, a groundbreaking treatment for metastatic and recurrent nasopharyngeal cancer.

Novocure this week announced positive topline results from its Phase 3 trial of its Tumor Treating Fields for pancreatic cancer.

Final data demonstrate CM24 in combination with nivolumab and Nal-IRI/5FU/LV chemotherapy clear and consistent improvement ...